Is Ribomic Inc. (4591.T) a Buy, Sell, or Hold?
Ribomic Inc.
JPX:4591.T
$72 JPY
-$1 (-1.37%)
- Volume
- 334.4K
- Average Volume
- 1.57M
- Market Capitalization
- $4.03B
- P/E Ratio
- -3.12
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $127.00
- Year Low
- $57.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $21.68
Industry, Sector & symbol
| Stock Exchange | JPX |
| CEO | Yoshikazu Nakamura |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | 4591.T |
| CUSIP | None |
| CIK | None |
| Web | https://www.ribomic.com |
| Phone | 81 3 3440 3033 |
| Currency | JPY |
| Employees | 25 |
| Country | JP |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 21.68 |
| Quick Ratio | 21.66 |
| Cash Ratio | 14.27 |
Sales & Book Value
| Annual Sales | $3M |
| Price / Sales | 1342.77 |
| Cash Flow | -4.81 |
| Price / Cash Flow | -15.79 |
| Price / Book | 1.34 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-23.07 |
| Trailing P/E Ratio | -3.12 |
| PEG Ratio | -0.39 |
| P/E Growth | -0.39 |
| Net Income | $-1.15B |
| Net Margin | -38178.67% |
| Pretax Margin | -38138.33% |
| Return on Equity | -37.81% |
| Return on Assets | -38.48% |
Financials Score
| AltmanZ Score | 16.46 |
| Piotroski Score | 2.00 |
| Working Capital | 2.79B |
| Total Assets | 2.98B |
| Ebit | -1.18B |
| Market Cap | 4.08B |
| Total Liabilities | 135.09M |
Poll Results
About Ribomic Inc. (JPX:4591.T) Stock
Ribomic Inc. is a Japanese biopharmaceutical company dedicated to identifying and advancing medicinal compounds. The firm employs RNA aptamers in its drug development efforts, targeting various significant health issues such as wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma. Furthermore, Ribomic manufactures specialized separating agents used for the affinity purification of human IgG and Fc-fusion proteins. Established in 2003, the company's main operations are based in Tokyo, Japan. ...
Frequently Asked Questions
-
What is the current Ribomic Inc. (4591.T) stock price?
-
Ribomic Inc.(JPX:4591.T) stock price is $72 in the last trading session. During the trading session, 4591.T stock reached the peak price of $127 while $57 was the lowest point it dropped to. The percentage change in 4591.T stock occurred in the recent session was --1.37% while the dollar amount for the price change in 4591.T stock was -$-1.
-
4591.T's industry and sector of operation?
-
The JPX listed 4591.T is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of 4591.T?
-
Hisato Oiwa | Executive Officer, Head of Management Headquarters & Director
Masayuki Miyazaki | Executive Officer, GM of Business Administration Department
Yoshikazu Nakamura | Chief Executive Officer, President & Representative Director
|
| -
How many employees does 4591.T have?
-
Number of 4591.T employees currently stands at 25. 4591.T operates from Shirokanedai Usui Building, Tokyo, TY 108-0071, JP.
-
Link for 4591.T official website?
-
Official Website of 4591.T is: https://www.ribomic.com
-
How do I contact 4591.T?
-
4591.T could be contacted at phone #81 3 3440 3033 and can also be accessed through its website. 4591.T operates from Shirokanedai Usui Building, Tokyo, TY 108-0071, JP.
-
How many shares of 4591.T are traded daily?
-
The average number of 4591.T shares traded daily for last 3 months was 1.57M.
-
What is the market cap of 4591.T currently?
-
The market value of 4591.T currently stands at $4.03B with its latest stock price at $72